N@N

Glancy Binkow & Goldberg LLP, Representing Investors of MannKind Corporation, Announces Class Action Lawsuit and Seeks to Recov

^{Published on 2011-02-09 16:10:33 - Market Wire}
 

LOS ANGELES--([ BUSINESS WIRE ])--Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for the Central District of California on behalf of a class consisting of all persons or entities who purchased the securities of MannKind Corporation (aMannKinda or the aCompanya) (Nasdaq:MNKD) between June 25, 2010 and January 19, 2011, inclusive (the aClass Perioda).

A copy of the Complaint is available from the court or from Glancy Binkow & Goldberg LLP. Please contact us by phone to discuss this action or to obtain a copy of the Complaint at 310-201-9150 or Toll Free at 888-773-9224, by email at [ shareholders@glancylaw.com ], or visit our website at [ http://www.glancylaw.com ].

MannKind is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for diabetes and cancer. The Complaint alleges that during the Class Period the Company and certain of its executive officers violated federal securities laws by issuing material misrepresentations to the market concerning the Companya™s business, operations and prospects, thereby artificially inflating the price of MannKind securities. Specifically, the Complaint alleges that defendants misrepresented the prospects for U.S. Food and Drug Administration approval for the Companya™s lead product candidate, AFREZZA®, a rapid-acting insulin for the treatment of diabetes that has completed clinical trials in the United States, Europe and Japan.

Plaintiff seeks to recover damages on behalf of class members and is represented by law firms including Glancy Binkow & Goldberg LLP, a law firm with significant experience in prosecuting class actions, and substantial expertise in actions involving corporate fraud.

If you are a member of the class described above, you may move the Court, no later than April 1, 2011, to serve as lead plaintiff; however, you must meet certain legal requirements. If you wish to discuss this action or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1801 Avenue of the Stars, Suite 311, Los Angeles, California 90067, by telephone at 310-201-9150 or Toll Free at 888-773-9224, by e-mail to [ shareholders@glancylaw.com ], or visit our website at [ http://www.glancylaw.com ].